Navigation Links
Analysis of FDA Adverse Events Data Reveals at Least 106 Serious Conditions Reported Among Reglan Users
Date:5/8/2009

se of Reglan. Tardive dyskinesia is a neurological disorder characterized by involuntary, repetitive movements of the extremities, including lip smacking, grimacing, tongue protrusion, rapid eye movements or blinking, puckering and pursing of the lips, or impaired movement of the fingers. These symptoms are rarely reversible and there is no known treatment.

Because the risk of tardive dyskinesia may be greatest in patients who have taken Reglan or metoclopramide for an extended period, the FDA required a warning stating that chronic use of the drugs should be avoided, except in rare cases. According to the drug’s label, Reglan should only be prescribed for short-term use of four to 12 weeks. The safety of Reglan and metoclopramide use for longer than 12 weeks has not been studied.

“Tardive dyskinesia is a debilitating disease which substantially alters the quality of one’s life. It may affect thousands who used Reglan or metoclopramide,” says Shamus B. Mulderig, Managing Attorney of the Pharmaceutical and Medical Device Litigation Department at Hissey Kientz, LLP. “Tardive dyskinesia is a horrible affliction, is not reversible and has no cure. And because the FDA’s Adverse Event Reporting System is a voluntary reporting system, the number of reports received so far may seriously understate how widespread this affliction may be.”

Reglan is also linked to a serious and potentially fatal syndrome known as Neuroleptic Malignant Syndrome (NMS). Symptoms of NMS include hyperthermia, muscle rigidity, altered consciousness, irregular pulse, blood pressure or heartbeat or other symptoms.

An analysis conducted by the FDA found that, at a minimum, 20% of patients taking the drugs did so for longer than the three month maximum set by the
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Webcast Alert: Release of Economic Analysis Revealing $734 Billion in Savings Produced by Using Generic Medicines in 1999 - 2008
2. New data analysis shows possible link between childhood obesity and allergies
3. STIX Market Research Celebrates Ten Years of Technology/Market Analysis, Custom Research, and Niche Publishing; Prepares New Growth Phase
4. Genetic analysis may predict risk of invasive bladder cancer
5. Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide
6. How Can We Improve Our Elementary School System? - Unique Market Research Analysis of the Subconscious of Parents
7. China Medical Technologies Announces Receipt of SFDA Quality Testing Certificate for its SPR-based Analysis System
8. CDC analysis finds unique social and behavior intervention helps reduce MRSA rates up to 62 percent
9. Edifecs Announces New Version of Its Integrated HIPAA 5010 and ICD-10 Analysis and Migration Solution
10. An even-handed analysis of environmental policy
11. New Analysis: Light and Intermittent Smokers Overlooked in Traditional Tobacco Research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Analysis of FDA Adverse Events Data Reveals at Least 106 Serious Conditions Reported Among Reglan Users
(Date:3/30/2015)... March 30, 2015 Textile Exchange, a ... textile industry, today announced the latest version of its ... certification standard that can be applied to any waterfowl-based ... from hatchling to end product. The goal of the ... animal welfare and to enable traceability so that products ...
(Date:3/30/2015)... On March 11, 2015, Elle Magazine, in ... details six new treatment options for dealing with stubborn, unwanted ... a topical product. The other three technologies use devices to ... or freezing cold ( CoolSculpting ) to kill fat cells. ... to us to permanently remove unwanted fat," says Dr. Simon ...
(Date:3/30/2015)... Vancouver, BC (PRWEB) March 30, 2015 ... ( http://www.idataresearch.com ), the hernia repair market will continue ... market. Growth is occurring primarily due to increasing numbers ... to treat them. , “The significantly large market ... to a generally high ASP. We’re seeing a growing ...
(Date:3/30/2015)... This report studies the global tumor ... to 2019. , Based on the type of ... into four major segments, namely radio-frequency, microwave, cryoablation ... and laser ablation) segments. Moreover, based on type ... classified into three segments, namely, interventional radiology, surgery ...
(Date:3/30/2015)... On March 19th, 2015, in the Hall of Legends ... LiveToBeSober.org hosted the “Fighting Addiction Together” luncheon. Attendees included ... well as other civic leaders and public figures. , ... retired Detroit Lions wide receiver Herman Moore, Live to ... their own personal battles with addiction, Ronald Stevens and ...
Breaking Medicine News(10 mins):Health News:Responsible Down Standard 2.0 Released 2Health News:Responsible Down Standard 2.0 Released 3Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 3Health News:The Global Tumor Ablation Market is Poised to Reach the Value of $462.0 Million in 2019 - MarketsandMarkets Released Recently 2Health News:The Global Tumor Ablation Market is Poised to Reach the Value of $462.0 Million in 2019 - MarketsandMarkets Released Recently 3Health News:LiveToBeSober.org Releases Highlight Reel of Substance Abuse Conference Keynote Speakers 2
... Society (APS) is elated that the Senate has approved ... continue cutting-edge research that will lead to innovation, job ... Specifically, APS lauds the bill,s support of research programs ... National Science Foundation and the National Institute of Standards ...
... North Carolina students interested in earning the doctor of optometry ... by College Foundation of North Carolina and the N.C. State Education ... state:, , ... University (Greenville, NC) - 10:00 a.m. - 12:00 noon, ...
... yesterday, exactly six months after Hurricane Ike slammed the ... the lessons learned from Hurricane Rita. , According to ... they would evacuate if a Category 4 hurricane threatened ... 24 percent of residents who left during the Category ...
... Va., LONDON and GENEVA, March 13 Clinical Care ... and NAM, an award-winning community-based HIV information provider, have ... and news from the 5th International AIDS Society Conference ... Cape Town, South Africa, July 19-22, 2009, and the ...
... March 13 Transcept Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of proprietary products that address important ... it will report results for its fourth quarter 2008 ... conference call to review the results will begin at ...
... -- China Sky One Medical, Inc.,("China Sky One ... ), a leading fully,integrated pharmaceutical company producing over-the-counter ... announced that Ms. Xiao-yan Han,China Sky One Medical ... Jaffray,& ChinaVenture Conference in Shanghai and The World ...
Cached Medicine News:Health News:Optometry Career Conferences Set for Five N.C. Campuses in March 2Health News:Rice report shows lessons from Hurricane Rita not practiced during Ike 2Health News:Clinical Care Options and NAM Selected by the International AIDS Society to Collaborate on Official Online Conference Coverage From Annual Meetings 2Health News:Clinical Care Options and NAM Selected by the International AIDS Society to Collaborate on Official Online Conference Coverage From Annual Meetings 3Health News:Transcept Pharmaceuticals to Report Fourth Quarter 2008 Results 2Health News:Transcept Pharmaceuticals to Report Fourth Quarter 2008 Results 3Health News:China Sky One Medical to Attend Two Conferences in March 2Health News:China Sky One Medical to Attend Two Conferences in March 3
(Date:3/30/2015)... , March 30, 2015 ... My Diabetes Emergency Plan at the 2015 @NatHurricaneCon ... to be prepared to manage your #diabetes before emergencies ... (ACE) – the charitable, educational and scientific arm of ... joined forces with Lilly Diabetes to share the ...
(Date:3/30/2015)... Calif. , March 30, 2015  The investigational ... agent to alleviate certain menopause symptoms, such as hot ... March Journal of Women,s Health .[i] ... S- equol for menopausal vasomotor symptoms and possibly ... supporting safety of S- equol, physicians and health ...
(Date:3/30/2015)... March 30, 2015  A promising University of Michigan ... with a rare and lethal subtype of leukemia has ... with a new biotechnology company, Kura Oncology.  The Leukemia ... led by Assistant Professor Jolanta Grembecka , Ph.D, ... the University of Michigan, since 2009. ...
Breaking Medicine Technology:Preparation Is Personal for Those with Chronic Illnesses 2Preparation Is Personal for Those with Chronic Illnesses 3Preparation Is Personal for Those with Chronic Illnesses 4New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 2New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 3New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 4New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 5New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 6Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 2Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 3
... A unique treatment involving the use of hot chemotherapy ... Center. SJH&MC is the first hospital in Southeast Michigan ... offer the treatment. Know as Hyperthermic Intraperitoneal ... number of advanced cancers that have spread to the ...
... and SYDNEY, Nov. 4, 2011 HeartWare International, Inc. ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that CEO Doug Godshall is scheduled to ... 11:00 a.m. MST on Wednesday, November 9, 2011.  The ...
Cached Medicine Technology:St. John Hospital 1st in Region to Offer Innovative Chemotherapy Delivery System 2HeartWare to Present at the Credit Suisse 2011 Healthcare Conference 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: